United States - English - NLM (National Library of Medicine)

rhodes pharmaceuticals l.p. - dexmethylphenidate hydrochloride (unii: 1678ok0e08) (dexmethylphenidate - unii:m32rh9mfgp) - dexmethylphenidate hydrochloride 2.5 mg - dexmethylphenidate hydrochloride tablets are indicated for the treatment of attention deficit hyperactivity disorder (adhd) [see clinical studies (14)]. - hypersensitivity to methylphenidate or other components of dexmethylphenidate hydrochloride tablets. hypersensitivity reactions, such as angioedema and anaphylactic reactions, have been reported in patients treated with methylphenidate [see adverse reactions (6.1)]. - concomitant treatment with monoamine oxidase inhibitors (maois), or within 14 days following discontinuation of treatment with an maoi, because of the risk of hypertensive crises [see drug interactions (7.1)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to adhd medications, including dexmethylphenidate hydrochloride tablets, during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for adhd medications at 1-866-961-2388 or visit https://womensmentalhealth.org/ad

Ireland - English - HPRA (Health Products Regulatory Authority)

medice arzneimittel putter gmbh & co. k.g - methylphenidate hydrochloride - tablet - 20 milligram(s) - centrally acting sympathomimetics; methylphenidate

Ireland - English - HPRA (Health Products Regulatory Authority)

medice arzneimittel putter gmbh & co. k.g - methylphenidate hydrochloride - tablet - 10 milligram(s) - centrally acting sympathomimetics; methylphenidate

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

ranbaxy pharmaceutical (pty) ltd û roodepoort - tablet - see ingredients - each tablet contains clomipramine hydrochloride 25,0 mg

Israel - English - Ministry of Health

abic marketing ltd, israel - dipyrone - drops - dipyrone 500 mg / 1 ml - metamizole sodium - relief of moderate to severe pain as in headache, toothache, dysmenorrhea and for high fever that does not respond to other measures.

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis ireland limited - methylphenidate hydrochloride - prolonged-release capsule, hard - 30 milligram(s) - centrally acting sympathomimetics; methylphenidate

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis ireland limited - methylphenidate hydrochloride - prolonged-release capsule, hard - 20 milligram(s) - centrally acting sympathomimetics; methylphenidate

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis ireland limited - methylphenidate hydrochloride - prolonged-release capsule, hard - 40 milligram(s) - centrally acting sympathomimetics; methylphenidate

Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

yousif mahmood hussain & bahrain pharmacy co - propyphenazone - tablet - 220

Kenya - English - Pharmacy and Poisons Board

novartis pharma services inc 46057 00100 nairobi - methylphenidate - tablet - 10mg - psychostimulants agents used foradhdand